Jan-Olav Henck, PhD,
chief scientific officer
Jan-Olav Henck, PhD, chief scientific officer at Aptuit, discusses strategies and considerations in polymorph screening with Patricia Van Arnum, senior editor of Pharmaceutical Technology (Posted November 2011).
The 12th Annual Report and Survey of Biomanufacturing is now available.
Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.
Catalent’s Singapore facility is awarded GMP certification.
The International Conference on Harmonization Steering Committee appoints Dr. Dawn Ronan as the new director of the ICH Secretariat.
The US Pharmacopeial Convention hosts compliance seminar at CPhI China 2015.
Pharmacy associates say more education regarding the transactional requirements of DSCSA is needed.
Ingredients Insider Cynthia ChallenerNew Ways Around Hazardous Reagent Chemistry